Five UK organizations are calling for further discussions about the potential use of gene editing technologies such as CRISPR/Cas-9 for human germline editing, even as some are calling for a ban on the technology for such purposes.  

In a statement issued today, the organizations say that while UK law prohibits germline editing for clinical purposes, "there may be future potential to apply genome editing in a clinical context using human germ cells or embryos." 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more